# Olanzapine in OUD Patients

> **NCT05179772** · PHASE2 · WITHDRAWN · sponsor: **University of Pennsylvania**

## Conditions studied

- Opioid Use Disorder

## Interventions

- **DRUG:** Olanzapine

## Key facts

- **NCT ID:** NCT05179772
- **Lead sponsor:** University of Pennsylvania
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2022-07-28
- **Primary completion:** 2023-01-30
- **Final completion:** 2023-01-30
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** NIDA has advised us to terminate this protocol due to the difficulties in finding appropriate subjects.
- **Last updated:** 2023-02-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05179772

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05179772, "Olanzapine in OUD Patients". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT05179772. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*